|
|
Volumn 26, Issue 6, 2018, Pages 373-377
|
|
Effect of Bifidobacterium quadruple live bacteria on mayo score and serum levels of hs-CRP, IL-4, and IL-8 in patients with mild-to-moderate ulcerative colitis
|
|
Author keywords
Bifidobacterium quadruple live bacteria; Hs CRP; Interleukin 4; Interleukin 8; Mayo score; Ulcerative colitis
|
|
Indexed keywords
C REACTIVE PROTEIN;
INTERLEUKIN 4;
INTERLEUKIN 8;
MESALAZINE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
BIFIDOBACTERIUM;
CLINICAL EFFECTIVENESS;
CLINICAL EVALUATION;
CLINICAL FEATURE;
COMBINATION CHEMOTHERAPY;
CONTROLLED STUDY;
DISEASE SEVERITY;
ENDOSCOPY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HOSPITAL ADMISSION;
HUMAN;
IMMUNOTURBIDIMETRY;
MAJOR CLINICAL STUDY;
MAYO SCORE;
MONOTHERAPY;
NONHUMAN;
OBSERVATIONAL STUDY;
PROTEIN BLOOD LEVEL;
QUADRUPLE LIVE BACTERIA;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
REMISSION;
SCORING SYSTEM;
TREATMENT DURATION;
ULCERATIVE COLITIS;
|
|
EID: 85042669662
PISSN: 10093079
EISSN: None
Source Type: Journal
DOI: 10.11569/wcjd.v26.i6.373 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
